Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Aug 18;5(8):e620. doi: 10.1038/tp.2015.116

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2015 Macmillan Publishers Limited

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

Response rates at 24 weeks and 1 year according to treatment status in the EsDEPACS trial and K-DEPACS cohort. (a) EsDEPACS trial sample. HAM-D and BDI response rates at both 24 weeks and 1 year differed significantly among treatment groups (P=0.018, 0.045, 0.008 and 0.017, respectively). (b1) K-DEPACS cohort sample. HAM-D and BDI response rates at 1 year did not differ significantly according to statin use (P=0.388 and 0.773, respectively). (b2) K-DEPACS cohort sample. HAM-D and BDI response rates at 1 year were significantly higher in patients who took lipophilic statins than in those who took hydrophilic statins (P=0.011 and 0.042, respectively). BDI, Beck Depression Inventory; Esc., escitalopram; EsDEPACS, the Escitalopram for Depression in Acute Coronary Syndrome trial; HAM-D, Hamilton Depression Rating Scale; K-DEPACS, the Korean Depression in Acute Coronary Syndrome study; Med., medication.